Department of Military Affairs Tender by Indian Army (GEM/2025/B/6102307)
E IFA 11 Guaiphenesin Ip 100Mg Dextramethorphan 10Mg Phenylepherine 5Mg,E IFA 11 Gum Paint 15 Ml,E

Tender Timeline
Tender Title
DRUGS AND PHARMACEUTICALS
Reference Number
GEM/2025/B/6102307
Issuing Authority/Department
Department of Military Affairs, Ministry of Defence
Scope of Work and Objectives
The primary objective of this tender is to procure high-quality drugs and pharmaceuticals including various formulations such as Guaifenesin, Dextromethorphan, and Phenylephrine. The tender encompasses a total quantity of 169,236 units, focusing on delivering essential healthcare products that meet stringent quality and safety standards.
Eligibility Criteria
To participate in this tender, the bidding entities must be legitimate and registered as manufacturers or authorized dealers of pharmaceuticals. Eligibility requirements include possessing appropriate certifications, licenses, and fulfilling statutory obligations necessary for the manufacturing and distribution of drugs and pharmaceuticals.
Technical Requirements
Bidders should comply with the technical specifications stipulated within the tender documentation. These specifications generally involve ensuring that all products meet the pharmaceutical standards set forth by relevant authorities, which include but are not limited to manufacturing processes, ingredient sourcing, and packaging requirements.
Financial Requirements
Willing bidders must demonstrate their financial capability by providing documentation that reflects their financial health. This includes a detailed balance sheet, profit and loss statement, and evidence of previous successful contracts within the pharmaceutical domain.
Document Submission Details
All required documents must be submitted electronically via the provided online portal. It is essential that bidders adhere to the file format requirements specified in the tender documentation, ensuring that all documents are complete and accurate.
Special Provisions
The tender promotes inclusivity by providing advantages for Micro, Small, and Medium Enterprises (MSEs) and startups. Participating MSEs may be eligible for bidding incentives and may receive additional consideration during the evaluation phase, encouraging their involvement in government procurement processes.
Evaluation Process
The evaluation process will systematically review bids based on price and compliance with technical specifications. Bids fulfilling mandatory requirements will progress to further analysis. The final decision will prioritize quality, cost-effectiveness, and adherence to compliance standards.
Delivery Locations
Successful bidders will be required to supply the drugs and pharmaceuticals to designated locations specified in the tender document. The geographical coverage of delivery will be confirmed upon individual contract finalization.
Contact Information
For any queries, interested bidders are encouraged to visit the official website of the Department of Military Affairs or contact the provided support channels as listed in the tender documentation.
Conclusion
This tender represents a significant opportunity for manufacturers and suppliers in the pharmaceutical sector to contribute to the medical needs of the Department of Military Affairs. Bidders are encouraged to fully understand the tender requirements and align their submissions accordingly to ensure compliance and competitiveness in the procurement process.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
6 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, either as a manufacturer or authorized dealer of pharmaceuticals. Participants must hold the relevant certifications and licenses as dictated by the regulating authorities. Demonstrating compliance with statutory obligations is also crucial.
Bidders are required to comply with specific technical specifications that adhere to the pharmaceutical standards outlined in the tender documentation. This includes ensuring product quality, sourcing of ingredients, manufacturing processes, and packaging standards.
Typically, the Earnest Money Deposit (EMD) is required to secure the bid and demonstrate the bidder’s commitment to the submission process. Specific EMD amounts and payment methods will be outlined clearly in the tender documentation, ensuring all participants are informed.
Documents must be submitted electronically via the official bidding portal provided in the tender. It’s important that all documents are in accepted formats, which typically include PDF or Word, as specified within the documentation.
Yes, the tender encourages participation from MSEs by providing advantages such as additional consideration in the evaluation process and possible financial incentives. This aligns with broader government initiatives to support small businesses and promote economic inclusivity within the pharmaceutical sector.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders